Open access · CC-BY
via OpenAlex
Decoding metabolic signatures in Alzheimer’s disease: a mitochondrial perspective
Daniele Bano, Dan Ehninger, Giacinto Bagetta
Cell Death Discovery · 2023 · ▲ 38 citations
Abstract
Alzheimer's disease (AD) is one of the most prevalent age-related neurodegenerative diseases and accounts for the majority of dementia cases worldwide. Tremendous ongoing efforts of basic and clinical research have expanded our knowledge on AD and its complex multifactorial pathogenesis. For sporadic AD, it is widely assumed that silent and early symptomatic stages initiate decades before the irreversible decline in cognitive abilities that ultimately lead to debilitating conditions. In addition to amyloid plaques and tau-containing neurofibrillary tangles as the most prominent hallmarks of AD lesions within the affected brain areas, we now possess a broader collection of pathological signatures that are associated with AD development and progression. In this regard, there is a substantial body of evidence suggesting that hypometabolism occurs in the brains of individuals at the prodromal stage before dementia is diagnosed, which may reflect an early role of metabolic dysfunction in AD. This perspective surveys the vast literature and critically assesses the current evidence demonstrating a mitochondrial contribution to AD. Additionally, we discuss our interpretations of the reported mitochondrial signatures and consider how altered mitochondrial bioenergetics may be an additional risk factor for AD pathogenesis.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1038/s41420-023-01732-3
- Canonical
- link ↗
- Fetched
- 2026-06-06 MST
Cite this
APA
Bano, D., Ehninger, D., & Bagetta, G. (2023). Decoding metabolic signatures in Alzheimer’s disease: a mitochondrial perspective. <em>Cell Death Discovery</em>. https://doi.org/10.1038/s41420-023-01732-3
Vancouver
Bano D, Ehninger D, Bagetta G. Decoding metabolic signatures in Alzheimer’s disease: a mitochondrial perspective. Cell Death Discovery. 2023. doi:10.1038/s41420-023-01732-3.
BibTeX
@article{daniele2023Decodi,
title = {Decoding metabolic signatures in Alzheimer’s disease: a mitochondrial perspective},
author = {Daniele Bano and Dan Ehninger and Giacinto Bagetta},
journal = {Cell Death Discovery},
year = {2023},
doi = {10.1038/s41420-023-01732-3},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cells 2026
Open access · OA
Mitochondrial Dysfunction in Alzheimer's Disease and Mitochondria-Targeted Therapeutics.
World Journal of Gastroenterology 2013
Open access · CC-BY
Mitochondrial DNA alterations and mitochondrial dysfunction in the progression of hepatocellular carcinoma
Oxidative Medicine and Cellular Longevity 2014
Open access · CC-BY
Mitochondrial Dysfunction: Different Routes to Alzheimer’s Disease Therapy
Cells 2025
Open access · CC-BY
Mitochondrial Dysfunction in Neurodegenerative Diseases
International Journal of Molecular Sciences 2022
Open access · CC-BY
The Role of Bioenergetics in Neurodegeneration
Antioxidants (Basel, Switzerland) 2026
Open access · OA